PTNT targets pure-play or the top 10 companiesthatderive material revenue from IP licensing, royalties, or franchising.The fund targetslicensors and royalty-driven businesses across sectors, including wireless patent holders that collect per-device royalties, semiconductor architecture companies that license core processor designs, software, media, brand, and trademark licensors, franchise operators, pharmaceutical and life sciences royalty companies, and precious metals streaming businesses.Using a bottom-up approach that combines fundamental analysis with thematic and quantitativescreening, the fund invests in US and international stocks of any market capitalization. Otherfactors include supply chain positioning, growth potential, and valuation. Up to 15% may beallocatedto illiquid investments, including passive minority interests in SPVs. Holdings may include cash, cash equivalents, or short-term US treasuries for liquidity or portfolio management.

McDonald's Corporation

QUALCOMM Incorporated

The Walt Disney Company

International Business Machines Corporation

Netflix, Inc.

Royalty Pharma plc

Cadence Design Systems, Inc.

Yum! Brands, Inc.

Synopsys, Inc.

Liberty Media Corporation

Technology

Consumer Cyclical

Communication Services

Healthcare

Industrials

Corgi ETF Trust I - Corgi IP Licensing & Royalties ETF

Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey. Address: 11 Deer Park Drive, Monmouth Junction, NJ, United States, 08512

PTNT Holdings & Sector Breakdown